Patents by Inventor Jean-Paul Latge

Jean-Paul Latge has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • GALACTOSAMINOGALACTAN COMPRISING alpha-1-4 LINKED GALACTOSE AND alpha-1-4 LINKED N-ACETYLGALACTOSAMINE FOR USE IN THE TREATMENT OF AT LEAST ONE INFLAMMATORY DISEASE
    Publication number: 20160008391
    Abstract: A first object of the invention is galactosaminogalactan comprising ?1-4 linked galactose, ?1-4 linked N-acetylgalactosamine, and optionally ?1-4 linked galactosamine, for use in the treatment of at least one inflammatory disease. Another object of the invention is a pharmaceutical composition comprising a galactosaminogalactan comprising ?1-4 linked galactose, ?1-4 linked N-acetylgalactosamine, and optionally ?1-4 linked galactosamine, as defined herein, and optionally a pharmaceutically acceptable carrier. Another object of the invention is a pharmaceutical composition according to the invention, for use in the treatment of at least one inflammatory disease. Another object of the invention is an inhibitor of IL-1RA for use in the treatment of human fungal diseases. Another object of the invention is a pharmaceutical composition comprising an inhibitor of IL-1RA, and optionally a pharmaceutically acceptable carrier.
    Type: Application
    Filed: January 14, 2014
    Publication date: January 14, 2016
    Inventors: Jean-Paul LATGE, Thierry Vincent Gérard FONTAINE, Frank Leo VAN DE VEERDONK, Mark Sebastiaan GRESNIGT, Mihai NETEA, Leo AB JOOSTEN, Luigina ROMANI, Silvia BOZZA, Antonella DE LUCA
  • METHOD OF IN VITRO DIAGNOSING A PELLICULAR STATE IN A SUBJECT AND RELATED APPLICATIONS
    Publication number: 20150152486
    Abstract: The present invention relates to a method of diagnosing a pellicular state in a subject, to a screening method of identifying an antidandruff agent, and to kits and nucleic acid arrays useful for said methods.
    Type: Application
    Filed: July 13, 2012
    Publication date: June 4, 2015
    Applicant: L'Oreal S.A.
    Inventors: Isabelle Mouyna, Cecile Clavaud, Christiane Bouchier, Jean-Paul Latge, Lionel Breton
  • In vitro diagnostic method and kit for an infection
    Patent number: 7888041
    Abstract: The present invention relates to a method for the in vitro diagnosis of an Aspergillus infection by determining in the serum or plasma sample of a subject the quantity of antibodies directed against a combination of at least two of the ribonuclease (RNU), catalase (CA) and dipeptidylpeptidase V (DPPV) Aspergillus antigens. The invention also relates to a diagnostic kit comprising said combination.
    Type: Grant
    Filed: June 30, 2006
    Date of Patent: February 15, 2011
    Assignee: Institut Pasteur
    Inventors: Anne Beauvais, Jean-Paul Debeaupuis, Jean-Paul Latge, Sophie Paris, Jacqueline Sarfati
  • In Vitro Diagnostic Method and Kit for an Aspergillus Infection
    Publication number: 20090305312
    Abstract: The present invention relates to a method for the in vitro diagnosis of an Aspergillus infection by determining in the serum or plasma sample of a subject the quantity of antibodies directed against a combination of at least two of the ribonuclease (RNU), catalase (CA) and dipeptidylpeptidase V (DPPV) Aspergillus antigens. The invention also relates to a diagnostic kit comprising said combination.
    Type: Application
    Filed: June 30, 2006
    Publication date: December 10, 2009
    Inventors: Anne Beauvais, Jean-Paul Debeaupuis, Jean-Paul Latge, Sophie Paris, Jacqueline Sarfati
  • Method for sorting antifungal molecules acting on the glucanosyltransferase activity
    Publication number: 20060211013
    Abstract: The invention discloses proteins having ?(1-3)glucanosyltransferase type activities. These proteins can be used for detecting the antifungal activity of molecules.
    Type: Application
    Filed: January 6, 2006
    Publication date: September 21, 2006
    Inventors: Thierry Fontaine, Robbert Hartland, Isabelle Mouyna, Jean-Paul Latge
  • Method for sorting antifungal molecules acting on the glucanosyltransferase activity
    Patent number: 7060454
    Abstract: The invention discloses proteins having ? (1–3)glucanosyltransferase type activities. These proteins can be used for detecting the antifungal activity of molecules.
    Type: Grant
    Filed: January 21, 2003
    Date of Patent: June 13, 2006
    Assignee: Institut Pastuer
    Inventors: Thierry Fontaine, Robbert Hartland, Isabelle Mouyna, Jean-Paul Latge
  • Method for sorting antifungal molecules acting on the glucanosyltransferase activity
    Patent number: 7022495
    Abstract: The invention discloses proteins having ?(1-3)glucanosyltransferase type activities. These proteins can be used for detecting the antifungal activity of molecules.
    Type: Grant
    Filed: January 21, 2003
    Date of Patent: April 4, 2006
    Assignee: Institut Pasteur
    Inventors: Thierry Fontaine, Robbert Hartland, Isabelle Mouyna, Jean-Paul Latge
  • Method for sorting antifungal molecules acting on the glucanosyltransferase activity
    Publication number: 20030152986
    Abstract: The invention discloses proteins having &bgr;(1-3)glucanosyltransferase type activities. These proteins can be used for detecting the antifungal activity of molecules.
    Type: Application
    Filed: January 21, 2003
    Publication date: August 14, 2003
    Applicant: Institut Pasteur
    Inventors: Thierry Fontaine, Robbert Hartland, Isabelle Mouyna, Jean-Paul Latge
  • Method for sorting antifungal molecules acting on the glucanosyltransferase activity
    Publication number: 20030147856
    Abstract: The invention discloses proteins having &bgr; (1-3)glucanosyltransferase type activities. These proteins can be used for detecting the antifungal activity of molecules.
    Type: Application
    Filed: January 21, 2003
    Publication date: August 7, 2003
    Applicant: Institut Pasteur
    Inventors: Thierry Fontaine, Robbert Hartland, Isabelle Mouyna, Jean-Paul Latge
  • Method for sorting antifungal molecules acting on the glucanosyltransferase activity
    Patent number: 6551811
    Abstract: The invention discloses proteins having &bgr;(1-3)glucanosyltransferase type activities. These proteins can be used for detecting the antifungal activity of molecules.
    Type: Grant
    Filed: October 13, 1999
    Date of Patent: April 22, 2003
    Assignee: Institut Pasteur
    Inventors: Thierry Fontaine, Robbert Hartland, Isabelle Mouyna, Jean-Paul Latge
  • .beta.-(1-3)-glucanosyltransferase, oligonucleotides encoding this enzyme, and molecules having effects on this enzyme
    Patent number: 5989895
    Abstract: Protein having a .beta.-(1-3) glucanosyltransferase activity. This protein can be used for screening molecules for their antifungal activities.
    Type: Grant
    Filed: September 2, 1997
    Date of Patent: November 23, 1999
    Assignee: Institut Pasteur
    Inventors: Thierry Fontaine, Robbert Hartland, Isabelle Mouyna, Jean-Paul Latge